Delayed
OTC Markets
09:11:55 01/07/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.0001
USD
|
0.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
---|
Capitalization
1 |
358.3
|
215.3
|
95.12
|
22.37
|
Enterprise Value (EV)
1 |
332.2
|
250.1
|
124.3
|
39.47
|
P/E ratio
|
-18.8
x
|
-6.6
x
|
-0.35
x
|
-0.24
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
12,48,37,384
x
|
4,13,73,157
x
|
1,26,60,394
x
|
18,11,419
x
|
EV / Revenue
|
11,57,45,420
x
|
4,80,40,785
x
|
1,65,46,858
x
|
31,96,178
x
|
EV / EBITDA
|
-2,13,44,622
x
|
-58,37,842
x
|
-38,00,799
x
|
-19,84,732
x
|
EV / FCF
|
-2,10,71,329
x
|
-37,70,149
x
|
-54,57,716
x
|
-21,42,104
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
9.49
x
|
3.11
x
|
1.18
x
|
0.84
x
|
Nbr of stocks (in thousands)
|
86,700
|
1,06,979
|
2,89,678
|
4,01,454
|
Reference price
2 |
4.133
|
2.013
|
0.3284
|
0.0557
|
Announcement Date
|
04/04/19
|
30/04/20
|
28/04/21
|
20/05/22
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net sales
|
-
|
-
|
2.87
|
5.205
|
7.513
|
12.35
|
EBITDA
|
-
|
-3.069
|
-15.57
|
-42.83
|
-32.71
|
-19.88
|
EBIT
1 |
-2.612
|
-3.148
|
-16.55
|
-44.65
|
-37.95
|
-30.77
|
Operating Margin
|
-
|
-
|
-576.47%
|
-857.89%
|
-505.16%
|
-249.17%
|
Earnings before Tax (EBT)
1 |
-2.612
|
-2.805
|
-17.91
|
-37.72
|
-133.8
|
-92.12
|
Net income
1 |
-1.323
|
-1.909
|
-15.4
|
-30.69
|
-125.6
|
-85.53
|
Net margin
|
-
|
-
|
-536.55%
|
-589.7%
|
-1,672.05%
|
-692.68%
|
EPS
2 |
-0.0600
|
-0.0507
|
-0.2200
|
-0.3049
|
-0.9490
|
-0.2294
|
Free Cash Flow
|
-
|
-8.704
|
-15.77
|
-66.32
|
-22.78
|
-18.42
|
FCF margin
|
-
|
-
|
-549.3%
|
-1,274.24%
|
-303.18%
|
-149.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/09/18
|
19/09/18
|
04/04/19
|
30/04/20
|
28/04/21
|
20/05/22
|
Fiscal Period: December |
2020 Q2
|
2020 Q3
|
2020 Q4
|
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
---|
Net sales
1 |
2.314
|
2.823
|
1.6
|
3.834
|
2.172
|
2.541
|
3.801
|
3.463
|
EBITDA
1 |
-2.876
|
-3.482
|
-5.4
|
-3.522
|
-5.466
|
-7.494
|
-5.154
|
-2.432
|
EBIT
|
-7.301
|
-10.2
|
-101.2
|
-8.016
|
-5.924
|
-8.271
|
-
|
-
|
Operating Margin
|
-315.51%
|
-361.39%
|
-6,327.06%
|
-209.08%
|
-272.74%
|
-325.5%
|
-
|
-
|
Earnings before Tax (EBT)
|
-6.908
|
-10.43
|
-103.7
|
-8.887
|
-7.646
|
-9.374
|
-
|
-
|
Net income
|
-5.438
|
-9.717
|
-100.5
|
-8.277
|
-7.204
|
-8.774
|
-
|
-
|
Net margin
|
-235%
|
-344.21%
|
-6,278.37%
|
-215.88%
|
-331.68%
|
-345.3%
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/08/20
|
24/11/20
|
28/04/21
|
28/05/21
|
30/08/21
|
29/11/21
|
20/05/22
|
30/05/22
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
-
|
-
|
-
|
34.7
|
29.2
|
17.1
|
Net Cash position
1 |
1.12
|
7.75
|
26.1
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.8102
x
|
-0.8927
x
|
-0.8599
x
|
Free Cash Flow
|
-
|
-8.7
|
-15.8
|
-66.3
|
-22.8
|
-18.4
|
ROE (net income / shareholders' equity)
|
-
|
-23.9%
|
-45.3%
|
-35.5%
|
-96.6%
|
-111%
|
ROA (Net income/ Total Assets)
|
-
|
-15.2%
|
-23.3%
|
-19.8%
|
-12%
|
-14.3%
|
Assets
1 |
-
|
12.54
|
66
|
154.9
|
1,047
|
596.2
|
Book Value Per Share
2 |
0.0500
|
0.2900
|
0.4400
|
0.6500
|
0.2800
|
0.0700
|
Cash Flow per Share
2 |
0.0300
|
0.1300
|
0.3200
|
0.1000
|
0.0600
|
0.0100
|
Capex
|
-
|
8.04
|
14.7
|
51.8
|
15.5
|
1.35
|
Capex / Sales
|
-
|
-
|
511.81%
|
994.77%
|
205.82%
|
10.94%
|
Announcement Date
|
19/09/18
|
19/09/18
|
04/04/19
|
30/04/20
|
28/04/21
|
20/05/22
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 42.65K | | +27.29% | 5.56B | | -33.07% | 3.55B | | -5.20% | 3.01B | | -25.56% | 2.64B | | -10.76% | 2.3B | | +42.02% | 1.95B | | +48.03% | 1.52B | | -11.69% | 1.45B | | +43.81% | 1.38B |
Alternative Medicine
|